300404 博济医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.1982.9832.6883.3166.180
总资产报酬率 ROA (%)1.4421.9991.8072.3024.119
投入资产回报率 ROIC (%)1.7242.3352.0722.6294.822

边际利润分析
销售毛利率 (%)28.83230.37533.33637.93243.220
营业利润率 (%)3.1852.5053.1734.61114.508
息税前利润/营业总收入 (%)3.3052.6253.0955.59614.426
净利润/营业总收入 (%)4.0854.1324.8926.91813.418

收益指标分析
经营活动净收益/利润总额(%)161.026164.95697.999102.61281.140
价值变动净收益/利润总额(%)9.46316.49415.79715.2755.007
营业外收支净额/利润总额(%)-1.519-0.908-0.05220.4960.110

偿债能力分析
流动比率 (X)1.8991.9632.2802.3362.585
速动比率 (X)1.4021.4861.7231.7752.037
资产负债率 (%)33.61730.94231.41029.76925.640
带息债务/全部投入资本 (%)22.14819.06922.01920.43616.704
股东权益/带息债务 (%)347.894419.210348.080379.442486.142
股东权益/负债合计 (%)191.125216.867212.970226.979278.926
利息保障倍数 (X)19.69918.448-40.563-27.485-146.672

营运能力分析
应收账款周转天数 (天)84.39568.92266.68769.34563.470
存货周转天数 (天)140.082135.379178.493216.752236.171